D1000 Varejo stock: Q2 revenue reached BRL 668.47 million
Published on 11/09/2026 at 03:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSD1000 Varejo revenue remains above BRL 660 million
- D1000 Varejo reported quarterly revenue of BRL 668.47 million in the second quarter of 2026.
- Revenue increased 1.22 percent from the first quarter but remained below the third-quarter 2025 level.
D1000 Varejo's quarterly revenue reached BRL 668.47 million in the second quarter of 2026, according to TradingView. The figure was BRL 8.07 million, or 1.22 percent, above the first quarter.
Quarterly growth stays measured
The second-quarter figure followed revenue of BRL 660.39 million in the first quarter and BRL 690.31 million in the fourth quarter of 2025. Revenue was below the BRL 731.44 million reported for the third quarter of 2025, when the comparison base was higher.
TradingView's annual series shows revenue of BRL 2.67 billion for 2025, up 23.42 percent from 2024. The trailing-twelve-month figure stood at BRL 2.75 billion on the cited financial page, an increase of 3.14 percent.
Retail footprint and market position
D1000 Varejo is a Brazilian pharmacy retailer operating brands including Drogasmil, Drogaria Rosário, Drogarias Tamoio and Farmalife, according to the company's investor-relations website. Its business is centered on retail pharmacy operations in Brazil.
The company competes with other Brazilian pharmacy chains such as Raia Drogasil, Grupo DPSP and Pague Menos. D1000 Varejo is a smaller, multi-brand operator compared with the largest national chains, with a regional footprint across its pharmacy banners.
D1000 Varejo at a glance
- Company: D1000 Varejo Farma Participacoes SA
- Ticker: DMVF3
- Exchange: B3
- Second-quarter 2026 revenue: BRL 668.47 million
- Quarter-on-quarter change: plus 1.22 percent
